138 related articles for article (PubMed ID: 28865438)
1. Adjuvant chemotherapy versus chemoradiotherapy for small cell lung cancer with lymph node metastasis: a retrospective observational study with use of a national database in Japan.
Urushiyama H; Jo T; Yasunaga H; Yamauchi Y; Matsui H; Hasegawa W; Takeshima H; Hiraishi Y; Mitani A; Fushimi K; Nagase T
BMC Cancer; 2017 Sep; 17(1):613. PubMed ID: 28865438
[TBL] [Abstract][Full Text] [Related]
2. Benefits of postoperative radiotherapy in multimodality treatment of resected small-cell lung cancer with lymph node metastasis.
Liu WS; Zhao LJ; Wang S; Gong LL; Liu ZY; Yuan ZY; Wang P
Eur J Surg Oncol; 2014 Sep; 40(9):1156-62. PubMed ID: 24655801
[TBL] [Abstract][Full Text] [Related]
3. Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgery.
Thomas DC; Arnold BN; Rosen JE; Salazar MC; Blasberg JD; Detterbeck FC; Boffa DJ; Kim AW
Lung Cancer; 2017 Jan; 103():75-81. PubMed ID: 28024700
[TBL] [Abstract][Full Text] [Related]
4. Surgery Versus Optimal Medical Management for N1 Small Cell Lung Cancer.
Yang CJ; Chan DY; Speicher PJ; Gulack BC; Tong BC; Hartwig MG; Kelsey CR; D'Amico TA; Berry MF; Harpole DH
Ann Thorac Surg; 2017 Jun; 103(6):1767-1772. PubMed ID: 28385378
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy of radiotherapy between postoperative mediastinal lymph node recurrence and stage III disease in non-small cell lung cancer patients.
Imai H; Murakami H; Yoshino R; Mori K; Sumita K; Ono A; Akamatsu H; Taira T; Kenmotsu H; Harada H; Naito T; Kaira K; Tomizawa Y; Ohde Y; Matsuura M; Endo M; Saito R; Nakajima T; Takahashi T
J BUON; 2016; 21(2):333-40. PubMed ID: 27273942
[TBL] [Abstract][Full Text] [Related]
6. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Impact of Node-Spreading Pattern in Surgically Treated Small-Cell Lung Cancer: A Multicentric Analysis.
Leuzzi G; Lococo F; Alessandrini G; Sperduti I; Spaggiari L; Venuta F; Rendina EA; Granone PM; Rapicetta C; Zannini P; Di Rienzo G; Nicolosi M; Facciolo F
Lung; 2017 Feb; 195(1):107-114. PubMed ID: 27738827
[TBL] [Abstract][Full Text] [Related]
8. Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio.
Renaud S; Falcoz PE; Olland A; Reeb J; Santelmo N; Massard G
Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):222-7. PubMed ID: 25413781
[TBL] [Abstract][Full Text] [Related]
9. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
[TBL] [Abstract][Full Text] [Related]
10. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
11. Survival and prognostic factors in limited stage small cell lung cancer: A retrospective study from northeast Turkey.
Aynaci Ö; Canyilmaz E; Serdar L; Kandaz M; Bahat ZM; Yoney A
J Cancer Res Ther; 2016; 12(1):238-43. PubMed ID: 27072244
[TBL] [Abstract][Full Text] [Related]
12. The effect of adjuvant chemoradiotherapy on survival after R0 resection for stage III-N2 nonsmall cell lung cancer: A meta-analysis.
Li D; Li W; Pang Y; Xu L; Xu X
Medicine (Baltimore); 2022 Jul; 101(28):e29580. PubMed ID: 35839033
[TBL] [Abstract][Full Text] [Related]
13. Is neoadjuvant chemotherapy mandatory for limited-disease small-cell lung cancer?
Xu YJ; Zheng H; Gao W; Jiang GN; Xie HK; Chen C; Fei K
Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):887-93. PubMed ID: 25156899
[TBL] [Abstract][Full Text] [Related]
14. Distinguish the Role of Radiotherapy From Chemoradiotherapy for Gastric Cancer With Behavior of Metastasis-Indolent in Lymph Node.
Zhi Y; Lin Z; Ma J; Mou W; Chen X
Technol Cancer Res Treat; 2020; 19():1533033820959400. PubMed ID: 33148125
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
[TBL] [Abstract][Full Text] [Related]
16. Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer.
Morimoto M; Okishio K; Akira M; Omachi N; Tamiya A; Asami K; Kawaguchi T; Atagi S
Clin Lung Cancer; 2017 Mar; 18(2):e117-e127. PubMed ID: 28340925
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study.
Mahner S; Jueckstock J; Hilpert F; Neuser P; Harter P; de Gregorio N; Hasenburg A; Sehouli J; Habermann A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Thiel F; Mustea A; Meier W; du Bois A; Griebel LF; Woelber L;
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25618900
[TBL] [Abstract][Full Text] [Related]
18. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
19. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
[TBL] [Abstract][Full Text] [Related]
20. Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement.
Valan CD; Slagsvold JE; Halvorsen TO; Herje M; Bremnes RM; Brunsvig PF; Brustugun OT; Fløtten Ø; Levin N; Sundstrøm SH; Grønberg BH
Anticancer Res; 2018 Feb; 38(2):871-876. PubMed ID: 29374714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]